Evidence map›Paper›PMID 36297619›Full record

ArticlePharmaceutics2022

Comparative Estimation of the Cytotoxic Activity of Different Parts of

Amgad I M Khedr, Abdelaziz F S Farrag, Ali M Nasr, Shady A Swidan, Mohamed S Nafie, Maged S Abdel-Kader, Marwa S Goda, Jihan M Badr, Reda F A Abdelhameed

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Eco-Friendly Synthesis ofBioinorganic chemistry and applications · 2026
    Article
  2. Article
  3. Antimicrobial Profile of MoldovanAntibiotics (Basel, Switzerland) · 2025
    Article
  4. A Phytochemical and Biological Characterization ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Amgad I M KhedrDepartment of Pharmacognosy, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.ORCID 0000-0002-7658-4618
Abdelaziz F S FarragDepartment of Pharmacognosy, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.ORCID 0000-0001-8786-8184
Ali M NasrDepartment of Pharmaceutics, Faculty of Pharmacy, Port Said University, Port Said 42526, Egypt.
Shady A SwidanDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, The British University in Egypt, El-Sherouk City, Cairo 11837, Egypt.ORCID 0000-0002-0861-2699
Mohamed S NafieDepartment of Chemistry, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0003-4454-6390
Maged S Abdel-KaderDepartment of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-5128-2656
Marwa S GodaDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0001-9291-8940
Jihan M BadrDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Reda F A AbdelhameedDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Suez Canal University · EGPort Said University · EGBritish University in Egypt · EGGalala UniversityPrince Sattam Bin Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different parts of

Indexed as

biomedical implementationsCynara scolymus L.cytotoxicgreen synthesissilver nanoparticles.

Identifiers

PMID36297619
PMCPMC9610270
OpenAlexW4306153494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.